Prevalence and Pattern of Resistance in NS5A/NS5B in Hepatitis C Chronic Patients Genotype 3 Examined at a Public Health Laboratory in the State of São Paulo, Brazil

PURPOSE: Globally, it is estimated that 71 million people are chronically infected with hepatitis C, and 10–20% of these will develop cirrhosis and hepatocellular carcinoma. The development of new direct-acting antiviral (DAA) drugs has contributed to sustained virological response (SVR), eliminatin...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Infect Drug Resist
Main Authors: de Torres Santos, Ana Paula, Martins Silva, Vanessa Cristina, Mendes-Corrêa, Maria Cássia, Lemos, Marcilio Figueiredo, de Mello Malta, Fernanda, Santana, Rúbia Anita Ferraz, Dastoli, Gregório Tadeu Fernando, de Castro, Vanessa Fusco Duarte, Pinho, João Renato Rebello, Moreira, Regina Célia
Format: Artigo
Jezik:Inglês
Izdano: Dove 2021
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7917774/
https://ncbi.nlm.nih.gov/pubmed/33658809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S247071
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki